LENVATINIB 4MG CAPSULES

Lenvatinib 4mg Capsules are an advanced prescription targeted anticancer therapy classified as a multikinase inhibitor. This precision oncology medicine is widely used in the treatment of differentiated thyroid cancer, hepatocellular carcinoma (liver cancer), and advanced renal cell carcinoma, often as part of combination therapy under specialist supervision.

Lenvatinib works by blocking tumor blood vessel formation (angiogenesis) and inhibiting critical cancer cell growth pathways. By disrupting these survival mechanisms, the medicine helps slow tumor progression, reduce cancer spread, and improve disease control in aggressive malignancies.

Taken strictly as prescribed by an oncologist, Lenvatinib Capsules support long-term targeted cancer management with clinically proven effectiveness. The oral capsule formulation offers convenient dosing while delivering powerful, focused anticancer action as part of a comprehensive treatment plan.

Product Features

• Multikinase inhibitor targeted therapy
• Used in thyroid, liver, and kidney cancers
• Inhibits tumor blood vessel formation
• Oral capsule for convenient administration
• Can be used alone or in combination therapy
• Prescription-only oncology medication

How It Helps

• Blocks tumor angiogenesis to reduce the blood supply to cancer cells
• Slows cancer cell growth and spread in aggressive tumors
• Helps control disease progression in thyroid, liver, and kidney cancers
• Supports long-term targeted cancer management under an oncologist’s care